Načítá se...
Advances in Receptor-Targeted Radiolabeled Peptides for Melanoma Imaging and Therapy
Melanocortin-1 receptor (MC1R) and very late antigen-4 (VLA-4, integrin α(4)β(1)) are 2 attractive molecular targets for developing peptide radiopharmaceuticals for melanoma imaging and therapy. MC1R- and VLA-4–targeting peptides and peptide-conjugated Cornell prime dots (C′ dots) can serve as deliv...
Uloženo v:
| Vydáno v: | J Nucl Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Society of Nuclear Medicine
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049342/ https://ncbi.nlm.nih.gov/pubmed/33277401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.120.243840 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|